Published on 26 Apr 2024 on Zacks via Yahoo Finance
Edwards Lifesciences Corporation EW reported adjusted earnings per share (EPS) of 66 cents in first-quarter 2024, surpassing the Zacks Consensus Estimate by 3.1%. The figure also increased 6.5% from the year-ago quarter’s level.
The quarter’s one-time adjustments primarily include certain litigation expenses and amortization of intangible assets, among others.